Mechanical tibial loading remotely suppresses brain tumors by dopamine-mediated downregulation of CCN4

Abstract

Mechanical loading to the bone is known to be beneficial for bone homeostasis and for suppressing tumor-induced osteolysis in the loaded bone. However, whether loading to a weight-bearing hind limb can inhibit distant tumor growth in the brain is unknown. We examined the possibility of bone-to-brain mechanotransduction using a mouse model of a brain tumor by focusing on the response to Lrp5-mediated Wnt signaling and dopamine in tumor cells. The results revealed that loading the tibia with elevated levels of tyrosine hydroxylase, a rate-limiting enzyme in dopamine synthesis, markedly reduced the progression of the brain tumors. The simultaneous application of fluphenazine (FP), an antipsychotic dopamine modulator, enhanced tumor suppression. Dopamine and FP exerted antitumor effects through the dopamine receptors DRD1 and DRD2, respectively. Notably, dopamine downregulated Lrp5 via DRD1 in tumor cells. A cytokine array analysis revealed that the reduction in CCN4 was critical for loading-driven, dopamine-mediated tumor suppression. The silencing of Lrp5 reduced CCN4, and the administration of CCN4 elevated oncogenic genes such as MMP9, Runx2, and Snail. In summary, this study demonstrates that mechanical loading regulates dopaminergic signaling and remotely suppresses brain tumors by inhibiting the Lrp5-CCN4 axis via DRD1, indicating the possibility of developing an adjuvant bone-mediated loading therapy.

References

[1] Kang KS, Robling AG. New insights into Wnt-Lrp5/6-b-catenin signaling in mechanotransduction. Front. Endocrinol., 2014, 5: 246

[2] Yavropoulou MP, Yovos JG. The molecular basis of bone mechanotransduction. J. Musculoskelet. Neuronal Interact., 2016, 16: 221-236

[3] Fan Y et al. Skeletal loading regulates breast cancer-associated osteolysis in a loading intensity-dependent fashion. Bone Res., 2020, 8: 9

[4] DeSantis CE et al. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J. Clin., 2016, 66: 31-42

[5] Scully OJ, Bay BH, Yip G, Yu Y. Breast cancer metastasis. Cancer Genom. Proteom., 2012, 9: 311-320

[6] Crozier JA, Cornell LF, Rawal B, Perez EA. Breast cancer brain metastases: molecular subtype, treatment and survival. Breast Dis., 2016, 36: 133-141

[7] O’Sullivan CC, Davarpanah NN, Abraham J, Bates SE. Current challenges in the management of breast cancer brain metastases. Semin. Oncol., 2017, 44: 85-100

[8] Kotecki, N., Lefranc, F., Devriendt, D. & Awada, A. Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives. Ther. Adv. Med. Oncol. 10, 1758835918780312 (2018).

[9] Owonikoko TK et al. Current approaches to the treatment of metastatic brain tumours. Nat. Rev. Clin. Oncol., 2014, 11: 203-222

[10] Sharif Y et al. Blood brain barrier: a review of its anatomy and physiology in health and disease. Clin. Anat., 2018, 31: 812-823

[11] Minami K et al. Inhibitory effects of dopamine receptor D1 agonist on mammary tumor and bone metastasis. Sci. Rep., 2017, 7

[12] Borcherding DC et al. Expression and therapeutic targeting of dopamine receptor 1 (D1R) in breast cancer. Oncogene, 2016, 35: 3103-3113

[13] Lan YL et al. Anti-cancer effects of dopamine in human glioma: involvement of mitochondrial apoptotic and anti-inflammatory pathways. Oncotarget, 2017, 8: 88488-88500

[14] Tardy, M., Dold, M., Engel, R. R. & Leucht, S. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 7, CD009396 (2014).

[15] Tardy, M., Huhn, M., Engel, R. R. & Leucht, S. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 8, CD009230 (2014).

[16] Wu D et al. Loading-induced antitumor capability of murine and human urine. FASEB J., 2020, 34: 7578-7592

[17] Tran S, Facciol A, Nowicki M, Chatterjee D, Gerlai R. Acute alcohol exposure increases tyrosine hydroxylase protein expression and dopamine synthesis in zebrafish. Behav. Brain Res., 2017, 317: 237-241

[18] Lindgren N et al. Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. Eur. J. Neurosci., 2002, 15: 769-773

[19] Rabbani SA, Arakelian A, Farookhi R. Lrp5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo. Cancer Med., 2013, 2: 625-635

[20] Yan R, Wang T, Zhou Q. Elevated dopamine signaling from ventral tegmental area to prefrontal cortical parvalbumin neurons drives conditioned inhibition. Proc. Natl. Acad. Sci. USA, 2019, 116: 13077-13086

[21] Sawakami K et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem., 2006, 281: 23698-23711

[22] Niziolek PJ, Warman ML, Robling AG. Mechanotransduction in bone tissue: The A214V and G171V mutations in Lrp5 enhance load-induced osteogenesis in a surface-selective manner. Bone, 2012, 51: 459-465

[23] Tammela T et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature, 2017, 545: 355-359

[24] Deng W, Fernandez A, McLaughlin SL, Klinke DJ 2nd. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma cell invasion and metastasis by promoting epithelial-mesenchymal transition. J. Biol. Chem., 2019, 294: 5261-5280

[25] Liu S et al. Osteocyte-driven downregulation of snail restrains effects of Drd2 inhibitors on mammary tumor cells. Cancer Res., 2018, 78: 3865-3876

[26] Tang Z et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res, 2017, 45: W98-W102

[27] Qiu F et al. Aerobic exercise enhanced endothelium-dependent vasorelaxation in mesenteric arteries in spontaneously hypertensive rats: the role of melatonin. Hypertens. Res., 2018, 41: 718-729

[28] Heyes MP, Garnett ES, Coates G. Central dopaminergic activity influences rat ability to exercise. Life Sci., 1985, 36: 671-677

[29] Shim JW et al. Physical weight loading induces expression of tryptophan hydroxylase 2 in the brain stem. PLoS One, 2014, 9

[30] Warner RL, Johnston C, Hamilton R, Skolnick MH, Wilson OB. Transcranial electrostimulation effects on rat opioid and neurotransmitter levels. Life Sci., 1994, 54: 481-490

[31] Yang K et al. Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity. Cell Oncol, 2020, 43: 1175-1190

[32] Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med., 2013, 19: 179-192

[33] Witzel I, Oliveira-Ferrer L, Pantel K, Müller V, Wikman H. Breast cancer brain metastases: biology and new clinical perspectives. Breast Cancer Res., 2016, 18

[34] Wehner T, Claes L, Simon U. Internal loads in the human tibia during gait. Clin. Biomech., 2009, 24: 299-302

[35] Burnett RM et al. Organ specific adaptive signaling pathway activation in metastatic breast cancer cells. Oncotarget, 2015, 6: 12682-12696

[36] Lelekakis M et al. A novel orthotopic model of breast cancer metastasis to bone. Clin. Exp. Metastasis., 1999, 17: 163-170

[37] Ewens A, Mihich E, Ehrke MJ. Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. Anticancer Res., 2005, 25: 3905-3915

[38] Cailleau R, Olive M, Cruciger QV. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. Vitro, 1978, 14: 911-915

[39] Chen A et al. Attraction and compaction of migratory breast cancer cells by bone matrix proteins through tumor-osteocyte interactions. Sci. Rep., 2018, 8: 5420

[40] Li F et al. Vinculin force sensor detects tumor-osteocyte interactions. Sci. Rep., 2019, 9

[41] Lewis Phillips GD et al. Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis. Breast Cancer Res Treat., 2017, 164: 581-591

[42] Soto MS, Sibson NR. Mouse models of brain metastasis for unraveling tumor progression. Adv. Exp. Med. Biol., 2016, 899: 231-244

[43] Yuan M et al. Direct activation of tachykinin receptors within baroreflex afferent pathway and neurocontrol of blood pressure regulation. CNS Neurosci. Ther., 2019, 25: 123-135

Funding

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)(R03 CA238555)

U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(R01 AR052144)